Breast Cancer: How to Know if You’re at Risk?

Woman wearing bandana.
Print icon
By Katherine Del Prato
Family Nurse Practitioner
Hartford HealthCare Cancer Institute

Millions of women and men have faced a breast cancer diagnosis. This year alone, 268,600 women and 2,670 men will be diagnosed with breast cancer.

When that person is a family member or friend, you may wonder what you can do to lower your risk and best protect your health.

Although most people diagnosed with breast cancer have no family history of the disease, those with a family history may be at higher risk. Participation in a high-risk surveillance program can give you peace of mind, concrete data and a proactive plan focused on preventing and detecting cancer as early as possible.

Here are some of the factors that can determine if you or a loved one have a higher-than-average risk of developing breast cancer.

Strong family history of breast cancer, which may include:

  • Immediate relative with a history of breast cancer under the age of 50.
  • Multiple family members with a history of breast or ovarian cancer.
  • Any male relatives with a history of breast cancer.
  • Ashkenazi Jewish ancestry.

Also:

  • Personal or family history of genetic mutations (such as BRCA 1, BRCA 2, Li-Fraumeni or Cowden syndrome).
  • History of radiation to the chest between the ages of 10 and 30.
  • A breast biopsy revealing atypical cells such as lobular carcinoma in situ or atypical hyperplasia.

By identifying risk factors, breast cancer specialists can offer a comprehensive risk assessment and recommend appropriate screening and preventative measures. For instance, in addition to a yearly screening mammogram, an ultrasound and/or breast MRI may be recommended. Risk-reducing medication and surgical options may also be considered.

An important component of the Hartford HealthCare Cancer Institute breast health services is its risk assessment and surveillance program. People can meet with one of our breast specialists regularly to review risk factors. During a visit, you’ll  have a clinical breast exam, discuss lifestyle strategies and review the personally tailored surveillance program that has been designed for them.

A unique feature of the Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut in Plainville is the option for same-day screening mammogram and ultrasound. Referrals may be made to other on-site services such as genetic counseling, medical oncology (to discuss potential risk-reducing medications, such as tamoxifen) or to plastic surgery (if risk-reducing surgery is being considered).

People working with a high-risk breast specialist along with the most advanced surveillance and diagnostic technology can take a proactive role in their breast health. If you or your health specialist believe that your risk of breast cancer may be higher than average, ask for a referral to meet with a high-risk breast specialist. The best way you can help spread awareness this October is to get your mammogram and encourage your loved ones to do the same.

For more information on the high-risk breast cancer surveillance program, click here.

Katherine Del Prato is a board-certified family nurse practitioner who specializes in high-risk breast cancer surveillance at Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut in Plainville. 

 

 


What's New

Healthy Diet

Cancer Survivors: Find The Power of a Healthy Diet

By Diane Avino Dietitian Gray Cancer Center Hartford HealthCare Cancer Institute at Hartford Hospital Eating well is important during all stages of life, but it’s particularly important for cancer survivorship. Adequate nutrition is a crucial part of staying well through cancer treatments as well as promoting your long-term health. Eating...

Immunotherapy

As Cancer Treatment Evolves, a Focus on Reducing Side Effects

By Dr. Omar Eton Melanoma DMT Lead Hartford HealthCare Cancer Institute Over the past two decades, there has been great progress in understanding the relationship between cancer and the defenses a patient can muster against it. This led to a Nobel Prize for James P. Allison and Tasuku Honjo in...

Stomach Cancer

Stomach Cancer: Signs You Shouldn’t Ignore

By Dr. Bret Schipper Chief of Surgical Oncology The Hospital of Central Connecticut and MidState Medical Center Stomach, or gastric, cancer in the United States is somewhat rare, but it’s important to know the signs and symptoms. According to the American Cancer Society, about 27,500 cases of stomach cancer will...

Dr. Bret Schipper

Dr. Bret Schipper, New Surgical Oncology Chief, Starts Seeing Patients

The Hartford HealthCare Cancer Institute has announced the appointment of Dr. Bret Schipper as chief of surgical oncology at Hartford Hospital and director of oncologic surgery for the entire Cancer Institute. Dr. Schipper’s areas of interest include hepatobiliary surgery, both benign and malignant; minimally-invasive robotic surgery; soft tissue (melanoma/sarcoma) and gastric...

Senior man giving wife a kiss

Why ‘Hot Chemo’ Can Be More Effective Than IV Against Cancer

While traditional chemotherapy drips intravenously into the body to circulate and attack deadly cancer cells, a faster, a more effective way of helping people with some cancers is now available at the Hartford HealthCare Cancer Institute. Called Hyperthermic Intraperitoneal Chemotherapy (HIPEC), the treatment is designed for people with cancers of...

Pancreatic Cancer

Where a Radiation Oncologist Fits in Your Pancreatic Cancer Treatment

Treating hepatobiliary cancer involves getting the most powerful treatment directly to the source of the disease, which is where the skill of a radiation oncologist often comes in. Dr. Timothy Boyd, a radiation oncologist with Hartford Hospital and part of the Hartford HealthCare Cancer Institute’s team approach to treating pancreatic...

Chemo

Targeted Chemo Treatments Promising for HPB Patients

Everyone knows the connection between chemotherapy and cancer. It’s treatment and disease. With pancreatic cancer, maybe more than in other cancers, chemotherapy constitutes an integral part of the treatment. Medical oncologists oversee the use of chemo and other systemic treatments in patients with cancer, according to Dr. Rawad Elias, a...